AstraZeneca Sues 4 Drugmakers To Stop Generic Vimovo

Law360, New York (October 25, 2013, 5:32 PM ET) -- AstraZeneca AB sued four generic drugmakers this week in New Jersey federal court, accusing the pharmaceutical companies of infringing on its patent for the arthritis medication Vimovo. 

AstraZeneca on Thursday sued three pharmaceutical companies — Dr. Reddy’s Laboratories Inc., Lupin Ltd. and Actavis Inc. — and another, Mylan Pharmaceuticals, on Wednesday, to stop generic forms of Vimovo from entering the market after the companies filed multiple abbreviated new drug applications with the U.S. Food and Drug Administration.

The suits center on U.S. Patent No. 8,557,285, entitled “Pharmaceutical...
To view the full article, register now.